Zobrazeno 1 - 10
of 238
pro vyhledávání: '"BETA-THALASSEMIA INTERMEDIA"'
Publikováno v:
Family Practice and Palliative Care, Vol 6, Iss 3, Pp 105-110 (2021)
Introduction: Beta-thalassemia is an autosomal recessive disease that occurs as a result of a disorder in the (β-globin chains synthesis), and the gold standard method for diagnosis is genetic mutation analysis. It is important to know the distribut
Externí odkaz:
https://doaj.org/article/437d8b7833c54a58a56eda643bccc74b
Publikováno v:
Clinical Case Reports, Vol 10, Iss 8, Pp n/a-n/a (2022)
Abstract Patients with chronic diseases are severely affected by acute coronavirus syndrome. In this regard, patients with beta thalassemia intermedia and diabetes mellitus (DM) are also at high risk for coronavirus‐induced respiratory failure. The
Externí odkaz:
https://doaj.org/article/f42708846e014b4f857a22918b3b9a71
Publikováno v:
Medicine Science, Vol 9, Iss 3, Pp 708-13 (2020)
Thalassemia is the most frequently seen monogenetic disorders around the world that is inherited as a recessive single-gene disease, resulting from mutations in α-or β-globin gene clusters. In this study Beta Thalassemia Intermedia, Beta Thalassemi
Externí odkaz:
https://doaj.org/article/f5d4d785265d499bb84c6ccfba9e534b
Autor:
Paloma Ropero, Fernando Ataúlfo González Fernández, Jorge M. Nieto, Williana Melissa Torres-Jiménez, Celina Benavente
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
ObjectivesTo verify with hematimetric data that the diagnosis and clinical grade of β-TI can be established when a triplication of alpha genes (αααanti 3.7) and heterozygous β-thalassemia coexist.Materials and MethodsRetrospective study in which
Externí odkaz:
https://doaj.org/article/0d431a33d3bd49f4ae7b9a467577ab04
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cornelis L. Harteveld, Ahlem Achour, Sandra J. G. Arkesteijn, Jeanet ter Huurne, Maaike Verschuren, Sharda Bhagwandien‐Bisoen, Rianne Schaap, Linda Vijfhuizen, Hakima el Idrissi, Tamara T. Koopmann
Publikováno v:
International Journal of Laboratory Hematology, 44, 28-36. WILEY
Hemoglobinopathies are the most common monogenic disorders in the world with an ever increasing global disease burden each year. As most hemoglobinopathies show recessive inheritance carriers are usually clinically silent. Programmes for preconceptio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c502b86fee3dee381b0fd10147f47ad
https://hdl.handle.net/1887/3563775
https://hdl.handle.net/1887/3563775
Publikováno v:
Güncel Pediatri. 18:237-250
INTRODUCTION: Main purpose of this study is to evaluate the effects of some genetic modifiers; especially by correcting the imbalance between alpha/non alpha chains on clinical severity of Turkish beta Thalassemia patients. MATERIALS and METHODS: Eig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed0e2fa69c4363c36a77ed0665a9908f
https://doi.org/10.4274/jcp.2020.0021
https://doi.org/10.4274/jcp.2020.0021
Publikováno v:
Journal of Research in Medical Sciences, Vol 15, Iss 3, Pp 150-154 (2010)
Background: Beta-thalassemia is considered to be the most frequent hereditary blood disorder worldwide. Lipid abnormalities have been detected in different types of beta-thalassemia. The aim of this study is to assess the lipid profiles in beta-thala
Externí odkaz:
https://doaj.org/article/d4eb5a61c5a14e62a630fd6b56e6d2e5
Publikováno v:
Current Journal of Neurology.
The article's abstract is not available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35a761979b7841e9cefdb08def81f5cb
https://doi.org/10.18502/cjn.v20i3.7694
https://doi.org/10.18502/cjn.v20i3.7694
Autor:
Ghada Samir Abd El-Halim Elsayed, Iman Ahmed Ragab, Tarek Mostafa Kamal, Shereen Mohamed Abd El-Ghany
Publikováno v:
QJM: An International Journal of Medicine. 114
Background β-thalassemia syndromes involve a collection of extremely diverse phenotypes. The term β-thalassemia intermedia (β-TI) was suggested to describe patients who had clinical manifestations that are too severe to be termed minor thalassemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79c2b33ddc535afe8c19639c4e55abee
https://doi.org/10.1093/qjmed/hcab113.024
https://doi.org/10.1093/qjmed/hcab113.024